Login / Signup

Hyperhaemolytic transfusion reaction in two β-thalassaemia major patients: The role of eculizumab.

Despoina PantelidouDimitrios PilalasStylianos DaiosGeorge PolychronopoulosDespoina PapadopoulouVassilios PerifanisChristos SavopoulosGeorgia D Kaiafa
Published in: Journal of clinical pharmacy and therapeutics (2021)
We report the successful management of hyperhaemolysis with eculizumab in a β-thalassemia major patient.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • case report
  • cardiac surgery
  • patient reported outcomes
  • patient reported